RaySearch Laboratories Unveils RayIntelligence® v2025: A Game Changer in Oncology Analytics
RaySearch Laboratories Introduces RayIntelligence® v2025
On September 1, 2025, RaySearch Laboratories AB publicly announced the launch of its updated oncology analytics system, RayIntelligence® v2025. This substantial upgrade promises to revolutionize how clinical data is processed and analyzed in oncology, allowing medical institutions to derive actionable insights from their vast data resources.
Enhancing Clinical Insights
RayIntelligence v2025 is engineered to integrate seamlessly with RaySearch's broader suite of products, including RayStation® and RayCare®. By connecting directly to primary oncology data sources, it addresses a common challenge in many clinics where oncology-related data is dispersed across multiple, often incompatible systems. This disorganization can hinder evidence-based improvements in treatment practices.
The system's new capabilities enable clinics to construct tailored dashboards that reflect their operational realities and priorities. Users can now track essential metrics such as plan quality trends, machine utilization, protocol adherence, and outcome indicators, which are critical for optimizing treatment protocols.
A New Era of Data-Driven Oncology
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.